280 related articles for article (PubMed ID: 27223297)
1. N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN.
Phoenix I; Nishiyama S; Lokugamage N; Hill TE; Huante MB; Slack OA; Carpio VH; Freiberg AN; Ikegami T
Viruses; 2016 May; 8(5):. PubMed ID: 27223297
[TBL] [Abstract][Full Text] [Related]
2. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
3. Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines.
Hofmann H; Li X; Zhang X; Liu W; Kühl A; Kaup F; Soldan SS; González-Scarano F; Weber F; He Y; Pöhlmann S
J Virol; 2013 Apr; 87(8):4384-94. PubMed ID: 23388721
[TBL] [Abstract][Full Text] [Related]
4. Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.
Liu L; Celma CC; Roy P
Virol J; 2008 Jul; 5():82. PubMed ID: 18638365
[TBL] [Abstract][Full Text] [Related]
5. Fine Mapping the Interaction Between Dendritic Cell-Specific Intercellular Adhesion Molecule (ICAM)-3-Grabbing Nonintegrin and the Cytomegalovirus Envelope Glycoprotein B.
Chéneau C; Coulon F; Porkolab V; Fieschi F; Laurant S; Razanajaona-Doll D; Pin JJ; Borst EM; Messerle M; Bressollette-Bodin C; Halary F
J Infect Dis; 2018 Jul; 218(3):490-503. PubMed ID: 29648611
[TBL] [Abstract][Full Text] [Related]
6. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
7. An equine herpesvirus type 1 (EHV-1) vector expressing Rift Valley fever virus (RVFV) Gn and Gc induces neutralizing antibodies in sheep.
Said A; Elmanzalawy M; Ma G; Damiani AM; Osterrieder N
Virol J; 2017 Aug; 14(1):154. PubMed ID: 28807043
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Molecular Interactions That Govern the Packaging of Viral RNA Segments into Rift Valley Fever Phlebovirus Particles.
Tercero B; Narayanan K; Terasaki K; Makino S
J Virol; 2021 Jun; 95(14):e0042921. PubMed ID: 33952635
[TBL] [Abstract][Full Text] [Related]
9. Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
Ly HJ; Lokugamage N; Nishiyama S; Ikegami T
PLoS One; 2017; 12(9):e0185194. PubMed ID: 28926632
[TBL] [Abstract][Full Text] [Related]
10. DC-SIGN as a receptor for phleboviruses.
Lozach PY; Kühbacher A; Meier R; Mancini R; Bitto D; Bouloy M; Helenius A
Cell Host Microbe; 2011 Jul; 10(1):75-88. PubMed ID: 21767814
[TBL] [Abstract][Full Text] [Related]
11. Generation and application of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein NP and glycoproteins Gn and Gc.
Jäckel S; Eiden M; Dauber M; Balkema-Buschmann A; Brun A; Groschup MH
Arch Virol; 2014 Mar; 159(3):535-46. PubMed ID: 24100475
[TBL] [Abstract][Full Text] [Related]
12. Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.
Phoenix I; Lokugamage N; Nishiyama S; Ikegami T
Viruses; 2016 May; 8(6):. PubMed ID: 27231931
[TBL] [Abstract][Full Text] [Related]
13. Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.
Ikegami T; Hill TE; Smith JK; Zhang L; Juelich TL; Gong B; Slack OA; Ly HJ; Lokugamage N; Freiberg AN
J Virol; 2015 Jul; 89(14):7262-76. PubMed ID: 25948740
[TBL] [Abstract][Full Text] [Related]
14. Differential Use of the C-Type Lectins L-SIGN and DC-SIGN for Phlebovirus Endocytosis.
Léger P; Tetard M; Youness B; Cordes N; Rouxel RN; Flamand M; Lozach PY
Traffic; 2016 Jun; 17(6):639-56. PubMed ID: 26990254
[TBL] [Abstract][Full Text] [Related]
15. Binding of DC-SIGN to glycoproteins expressed in glycoengineered Pichia pastoris.
Cukan MC; Hopkins D; Burnina I; Button M; Giaccone E; Houston-Cummings NR; Jiang Y; Li F; Mallem M; Mitchell T; Moore R; Nylen A; Prinz B; Rios S; Sharkey N; Zha D; Hamilton S; Li H; Stadheim TA
J Immunol Methods; 2012 Dec; 386(1-2):34-42. PubMed ID: 22982058
[TBL] [Abstract][Full Text] [Related]
16. Crucial role of the N-glycans on the viral E-envelope glycoprotein in DC-SIGN-mediated dengue virus infection.
Alen MM; Dallmeier K; Balzarini J; Neyts J; Schols D
Antiviral Res; 2012 Dec; 96(3):280-7. PubMed ID: 23124109
[TBL] [Abstract][Full Text] [Related]
17. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR.
Lin G; Simmons G; Pöhlmann S; Baribaud F; Ni H; Leslie GJ; Haggarty BS; Bates P; Weissman D; Hoxie JA; Doms RW
J Virol; 2003 Jan; 77(2):1337-46. PubMed ID: 12502850
[TBL] [Abstract][Full Text] [Related]
18. The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.
Nishiyama S; Lokugamage N; Ikegami T
J Virol; 2016 Jan; 90(7):3735-44. PubMed ID: 26819307
[TBL] [Abstract][Full Text] [Related]
19. Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.
Faburay B; Wilson W; McVey DS; Drolet BS; Weingartl H; Madden D; Young A; Ma W; Richt JA
Vector Borne Zoonotic Dis; 2013 Sep; 13(9):619-29. PubMed ID: 23962238
[TBL] [Abstract][Full Text] [Related]
20. DC-SIGN enhances infection of cells with glycosylated West Nile virus in vitro and virus replication in human dendritic cells induces production of IFN-alpha and TNF-alpha.
Martina BE; Koraka P; van den Doel P; Rimmelzwaan GF; Haagmans BL; Osterhaus AD
Virus Res; 2008 Jul; 135(1):64-71. PubMed ID: 18405996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
